Literature DB >> 33354711

Ketogenic diet and cognition in neurological diseases: a systematic review.

S Pavón1, E Lázaro1, O Martínez1, I Amayra1, J F López-Paz1, P Caballero1, M Al-Rashaida1, P M Luna1, M García1, M Pérez1, S Berrocoso1, A A Rodríguez1, P Pérez-Núñez1.   

Abstract

CONTEXT: In recent years, the ketogenic diet has gained special relevance as a possible therapeutic alternative to some neurological and chronic diseases.
OBJECTIVE: The aim of this systematic review was to answer the following question: Does a ketogenic diet improve cognitive skills in patients with Alzheimer's disease, Parkinson's disease, refractory epilepsy, and type 1 glucose deficiency syndrome? To define the research question, the PICOS criteria were used, following the guidelines of the PRISMA method. DATA SOURCES: Medline/PubMed, Elsevier Science Direct, Dialnet, EBSCOhost, Mediagraphic, Sage Journals, ProQuest, and Wiley Online Library databases were used. DATA EXTRACTION: After applying inclusion and exclusion criteria in accordance with the PRISMA method, a total of 63 entries published between 2004 and 2019 were used. DATA ANALYSIS: The records extracted were analyzed from a qualitative approach, so no statistical analysis was carried out.
CONCLUSION: Although scientific literature on the subject is scarce and there has tended to be a lack of scientific rigor, the studies reviewed confirmed the effectiveness of this diet in improving the cognitive symptomatology of the aforementioned diseases.
© The Author(s) 2020. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Alzheimer's diseasezzm321990 ; zzm321990 Parkinson's diseasezzm321990 ; zzm321990 cognitionzzm321990 ; zzm321990 glucose transporter deficiency syndrome type 1zzm321990 ; zzm321990 ketogenic dietzzm321990 ; zzm321990 ketosiszzm321990 ; zzm321990 low carbohydrate dietzzm321990 ; zzm321990 refractory epilepsyzzm321990 ; zzm321990 β-hydroxybutyratezzm321990

Mesh:

Year:  2021        PMID: 33354711     DOI: 10.1093/nutrit/nuaa113

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  8 in total

1.  Ketogenic Diet Therapy for Drug-Resistant Epilepsy and Cognitive Impairment in Children With Tuberous Sclerosis Complex.

Authors:  Yu Fang; Dan Li; Man Wang; Xia Zhao; Jing Duan; Qiang Gu; Baomin Li; Jian Zha; Daoqi Mei; Guangbo Bian; Man Zhang; Huiting Zhang; Junjie Hu; Liu Yang; Lifei Yu; Hua Li; Jianxiang Liao
Journal:  Front Neurol       Date:  2022-05-24       Impact factor: 4.086

Review 2.  The Therapeutic Role of Ketogenic Diet in Neurological Disorders.

Authors:  Diana Pietrzak; Kamila Kasperek; Paweł Rękawek; Iwona Piątkowska-Chmiel
Journal:  Nutrients       Date:  2022-05-06       Impact factor: 6.706

3.  Human oral microbiome cannot predict Pleistocene starch dietary level, and dietary glucose consumption is not essential for brain growth.

Authors:  Miki Ben-Dor; Raphael Sirtoli; Ran Barkai
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

4.  Effect of Ketogenic Diet on Quality of Life in Adults with Chronic Disease: A Systematic Review of Randomized Controlled Trials.

Authors:  Myriam Abboud; Fatme AlAnouti; Evridiki Georgaki; Dimitrios Papandreou
Journal:  Nutrients       Date:  2021-12-14       Impact factor: 5.717

5.  Ketogenic diet prevents chronic sleep deprivation-induced Alzheimer's disease by inhibiting iron dyshomeostasis and promoting repair via Sirt1/Nrf2 pathway.

Authors:  Yueqi Yang; Xueyan Wang; Aiai Xiao; Jun Han; Zhengping Wang; Min Wen
Journal:  Front Aging Neurosci       Date:  2022-09-01       Impact factor: 5.702

6.  Higher Total Cholesterol Concentration May Be Associated with Better Cognitive Performance among Elderly Females.

Authors:  Ke Pang; Chunxia Liu; Jianbin Tong; Wen Ouyang; Shuntong Hu; Yongzhong Tang
Journal:  Nutrients       Date:  2022-10-09       Impact factor: 6.706

7.  A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndrome.

Authors:  Pasquale Striano; Stéphane Auvin; Abigail Collins; Rita Horvath; Ingrid E Scheffer; Michal Tzadok; Ian Miller; Mary Kay Koenig; Adrian Lacy; Ronald Davis; Angela Garcia-Cazorla; Russell P Saneto; Melanie Brandabur; Susan Blair; Tony Koutsoukos; Darryl De Vivo
Journal:  Epilepsia       Date:  2022-05-21       Impact factor: 6.740

Review 8.  The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.

Authors:  Angelica Varesi; Elisa Pierella; Marcello Romeo; Gaia Bavestrello Piccini; Claudia Alfano; Geir Bjørklund; Abigail Oppong; Giovanni Ricevuti; Ciro Esposito; Salvatore Chirumbolo; Alessia Pascale
Journal:  Nutrients       Date:  2022-02-05       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.